Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Goodfellow Gems #199
Wednesday 2 August 2023, 12:38 AM

[Image: Kenny Eliason on Unsplash]
“Spironolactone may reduce atrial fibrillation incidence”
A systematic review of 10 trials of mineralocorticoid receptor antagonists (MRAs; eg, spironolactone) found a 23% reduction in the risk of atrial fibr
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
pubmed.ncbi.nlm.nih.gov/37269781 (Am J Cardiol 2023;199:85–91).